Search Within

Parastoo Bahrami Dahi

Formats
  1. Meeting Abstract (177)
  2. Journal Article (95)
  3. Research Letter (10)
  4. Review (8)
  5. Book Section (1)
  6. Correspondence (1)
  7. Editorial (1)
  8. Guidelines (1)
Groups
  1. Bone Marrow Transplant (294)
  2. CTCR Scholars (294)
  3. Center for Hematologic Malignancies (294)
  4. Department of Medicine (294)
  5. Hematologic Malignancies, Division of (294)
  6. MSK Grad Students (294)

More Groups

People
  1. Sergio Giralt (206)
  2. Miguel-Angel Perales (189)
  3. Gunjan Shah (155)
  4. Sean Devlin (155)
  5. Craig Sauter (135)
  6. Michael Scordo (133)

More People

Years
  1. 2025 (9)
  2. 2024 (19)
  3. 2023 (39)
  4. 2022 (27)
  5. 2021 (24)
  6. 2020 (47)

More Years

Publications
  1. Blood (86)
  2. Biology of Blood and Marrow Transplantation (69)
  3. Bone Marrow Transplantation (26)
  4. Transplantation and Cellular Therapy (25)
  5. Blood Advances (19)
  6. Leukemia and Lymphoma (8)

More Publications

Publishers
  1. American Society of Hematology (105)
  2. Elsevier Inc. (104)
  3. Nature Publishing Group (32)
  4. Taylor & Francis Group (10)
  5. Wiley Blackwell (8)
  6. American Society of Clinical Oncology (7)

More Publishers

Results (294)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Hematopoietic cell transplantation is feasible in patients with prior COVID-19 infection
    Journal Article

    Shah, N.; Dahi, P. B.; Ponce, D. M.; Sauter, C. S.; Shaffer, B. C.; Chung, D. J.; Politikos, I.; Lin, R. J.; Giralt, S. A.; Papanicolaou, G.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Immune reconstitution following high-dose chemotherapy and autologous stem cell transplantation with or without pembrolizumab maintenance therapy in patients with lymphoma
    Journal Article

    Merryman, R. W.; Redd, R.; Jeter, E.; Wong, J. L.; McHugh, K.; Reynolds, C.; Nazzaro, M.; Varden, A.; Brown, J. R.; Crombie, J. L.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Impact of TP53 genomic alterations in large B-cell lymphoma treated with CD19-chimeric antigen receptor T-cell therapy
    Journal Article

    Shouval, R.; Alarcon Tomas, A.; Fein, J. A.; Flynn, J. R.; Markovits, E.; Mayer, S.; Afuye, A. O.; Alperovich, A.; Anagnostou, T.; Besser, M. J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Allogeneic transplant and CAR-T therapy after autologous transplant failure in DLBCL: A noncomparative cohort analysis
    Journal Article

    Hamadani, M.; Gopal, A. K.; Pasquini, M.; Kim, S.; Qiu, X.; Ahmed, S.; Lazaryan, A.; Raj Bhatt, V.; Daly, A.; Lulla, P.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Novel agents may be preferable to chemotherapy for large B-cell lymphoma progressing after CD19-CAR-T: A multicenter observational study
    Meeting Abstract

    Tomas, A. A.; Fein, J. A.; Fried, S.; Fingrut, W.; Anagnostou, T.; Alperovich, A.; Shah, N.; Fraint, E.; Lin, R. J.; Scordo, M.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Prognostic value of minimal residual disease (MRD) among patients with classical Hodgkin lymphoma undergoing autologous stem cell transplantation
    Meeting Abstract

    Taranto, E.; Redd, R. A.; Jeter, E.; McHugh, K. M.; Brown, J. R.; Crombie, J. L.; Davids, M. S.; Fisher, D. C.; Freedman, A. S.; Jacobsen, E. D.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Five-year experience using bridging radiotherapy prior to chimeric antigen receptor (CAR) T-cell therapies for B-cell malignancies at Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Silverman, E. A.; Hubbeling, H.; Palomba, M. L.; Wijetunga, N. A.; Tringale, K.; Lebow, E.; Tomas, A. A.; Shouval, R.; Batlevi, C. L.; Brentjens, R. J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Daratumumab versus lenalidomide maintenance therapy for multiple myeloma: A randomized pilot study comparing patient-reported health related quality of life measures
    Meeting Abstract

    Shah, U. A.; Malik, M.; Werner, K.; Burge, M.; Devlin, S. M.; Mailankody, S.; Korde, N.; Hultcrantz, M.; Hassoun, H.; Tan, C.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Lesion characteristics and patterns of failure in diffuse large B cell lymphoma patients treated with bridging radiotherapy prior to chimeric antigen receptor T cell therapy
    Meeting Abstract

    Hubbeling, H.; Silverman, E. A.; Wijetunga, N. A.; Palomba, M. L.; Tringale, K.; Lebow, E.; Tomas, A. A.; Shouval, R.; Batlevi, C. L.; Brentjens, R. J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Successful incorporation of electronic patient-reported outcomes using PROMIS-29 into standard of care for lymphoma patients receiving CD19-directed chimeric antigen receptor T (CAR T) cell therapy
    Meeting Abstract

    Shah, G. L.; Scordo, M.; Sauter, C.; Batlevi, C.; Dahi, P. B.; Lin, R.; Palomba, M. L.; Perales, M. A.; Giralt, S. A.
    Quality of Life Research (2021)

    Fulltext@MSK | Save